Myrbetriq Audience Self-Identification Aug 31, 2016Aug 31, 2016 Brand: Myrbetriq (mirabegron), Tablets Parent Company: Astellas Drug Type: Prescription Drug Category: Urology Campaign: Post-Launch Targeting: Patients Patient Website: https://www.myrbetriq.com/ HCP Website: https://www.myrbetriqhcp.com/ Homepage with self-identification feature Awareness stage segment Desire stage segment Current patient segment Mobile view